Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Omitting Preoperative Alpha-blockade for Normotensive Pheochromocytoma
NCT05702944Phase 4Recruiting
- Sponsor
- Seoul National University Hospital
- Start
- Jan 2023
- Primary completion
- Aug 2027
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of phenoxybenzamine in pheochromocytoma, Paraganglioma (PGL), sponsored by Seoul National University Hospital. Started Jan 2023; status: recruiting.
02
Drugs
phenoxybenzamine
03
Conditions
pheochromocytomaParaganglioma (PGL)
Beyond the preview
Go deeper on NCT05702944.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05702944.